Ajinomoto Co Inc (2802):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Ajinomoto Co Inc (2802) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12365
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ajinomoto Co Inc (Ajinomoto) is a food products company that focuses on foods, bioscience fine chemicals and pharmaceuticals and health. It carries out research and development and production of seasonings, and provides Knorr cup soup products, processed foods, edible oils, sweeteners, beverages, amino acids, pharmaceuticals and specialty chemicals. The company also provides solutions for improved food resources, human health and global sustainability. Ajinomoto is also involved in wellness, packaging, logistics, and other services. Its products find applications in restaurants and institutions. The company has its operations in Europe, Africa, Japan, Asia and Americas. Ajinomoto is headquartered in Tokyo, Japan.

Ajinomoto Co Inc (2802) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ajinomoto Co Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ajinomoto Co Inc, Medical Devices Deals, 2012 to YTD 2018 9
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Ajinomoto Althea Forms Joint Venture with Ajinomoto OmniChem 11
Eisai Forms Joint Venture with Ajinomoto 12
Merger 13
Ajinomoto Althea Merges with Ajinomoto OmniChem 13
Licensing Agreements 14
Allena Pharma Amends Licensing Agreement With Althea Technologies 14
Ajinomoto North America Enters Into Licensing Agreement With Global Pharma Company For Corynex 15
Asset Transactions 16
Minafin Acquires Business Site in Louvain-la-Neuve from Ajinomoto OmniChem 16
Acquisition 17
Ajinomoto to Acquire GeneDesign 17
Ajinomoto Completes Acquisition Of Althea Technologies For US$175 Million 18
Ajinomoto Co Inc – Key Competitors 20
Ajinomoto Co Inc – Key Employees 21
Ajinomoto Co Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 25
Recent Developments 26
Strategy And Business Planning 26
Nov 29, 2017: Ajinomoto to Establish a New Development and Production Base for Oligonucleotide Drug Substances 26
Other Significant Developments 27
Apr 13, 2017: Ajinomoto OmniChem Launches Flow Chemistry for API Commercial Manufacturing 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ajinomoto Co Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ajinomoto Co Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Ajinomoto Co Inc, Medical Devices Deals, 2012 to YTD 2018 9
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ajinomoto Althea Forms Joint Venture with Ajinomoto OmniChem 11
Eisai Forms Joint Venture with Ajinomoto 12
Ajinomoto Althea Merges with Ajinomoto OmniChem 13
Allena Pharma Amends Licensing Agreement With Althea Technologies 14
Ajinomoto North America Enters Into Licensing Agreement With Global Pharma Company For Corynex 15
Minafin Acquires Business Site in Louvain-la-Neuve from Ajinomoto OmniChem 16
Ajinomoto to Acquire GeneDesign 17
Ajinomoto Completes Acquisition Of Althea Technologies For US$175 Million 18
Ajinomoto Co Inc, Key Competitors 20
Ajinomoto Co Inc, Key Employees 21
Ajinomoto Co Inc, Subsidiaries 23
Ajinomoto Co Inc, Joint Venture 25

List of Figures
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ajinomoto Co Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Ajinomoto Co Inc (2802):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HSBC Holdings Plc:企業のM&A・事業提携・投資動向
    HSBC Holdings Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HSBC Holdings Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Iroko Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Iroko Pharmaceuticals LLC (Iroko) is a pharmaceutical company that develops treatment options for responsible pain management. The company’s products comprise low dose Nonsteroidal anti-inflammatory drugs such as meloxicam, indomethacin, and diclofenac that are in various stages of nonclinic …
  • Kinder Morgan, Inc.:企業の戦略・SWOT・財務情報
    Kinder Morgan, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kinder Morgan, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • N V Nederlandse Gasunie:企業の戦略・SWOT・財務情報
    N V Nederlandse Gasunie - Strategy, SWOT and Corporate Finance Report Summary N V Nederlandse Gasunie - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • OMV AG (OMV):企業の財務・戦略的SWOT分析
    OMV AG (OMV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Kazanorgsintez (KZOS):企業の財務・戦略的SWOT分析
    Kazanorgsintez (KZOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Senseonics Inc:企業の戦略的SWOT分析
    Senseonics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Selexys Pharmaceuticals Corp-製薬・医療分野:企業M&A・提携分析
    Summary Selexys Pharmaceuticals Corp (Selexys Pharmaceuticals) is a biopharmaceutical company that develops drugs for the treatment of inflammatory and thrombotic diseases. The company’s products comprise Anti-P-selectin, which blocks selectin function and prevents white blood cells from initiating …
  • Vision RT Ltd:企業の戦略的SWOT分析
    Vision RT Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Tokuyama Corp (4043):企業の財務・戦略的SWOT分析
    Tokuyama Corp (4043) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Dixons Carphone plc:企業のM&A・事業提携・投資動向
    Dixons Carphone plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dixons Carphone plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Raytheon Technologies Corp (RTX):企業の財務・戦略的SWOT分析
    Raytheon Technologies Corp (RTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • SVOGL Oil Gas and Energy Ltd:企業の戦略的SWOT分析
    SVOGL Oil Gas and Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • InfraReDx Inc:医療機器:M&Aディール及び事業提携情報
    Summary Infraredx Inc (Infraredx), a subsidiary of Nipro Corp, is a cardiovascular imaging solutions provider. The company offers Makoto Intravascular Imaging System, Dualpro IVUS and Dualpro IVUS NIRS. It offers intravascular imaging catheter. Infraredx operates travascular imaging catheter utilizi …
  • Randall & Quilter Investment Holdings Ltd.:企業のM&A・事業提携・投資動向
    Randall & Quilter Investment Holdings Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Randall & Quilter Investment Holdings Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • SURUGA bank Ltd:企業の戦略・SWOT・財務情報
    SURUGA bank Ltd - Strategy, SWOT and Corporate Finance Report Summary SURUGA bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Grupo Ferrer Internacional SA:戦略・SWOT・企業財務分析
    Grupo Ferrer Internacional SA - Strategy, SWOT and Corporate Finance Report Summary Grupo Ferrer Internacional SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • transcosmos Inc:企業の戦略・SWOT・財務分析
    transcosmos Inc - Strategy, SWOT and Corporate Finance Report Summary transcosmos Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • AltheaDx Inc:医療機器:M&Aディール及び事業提携情報
    Summary AltheaDx Inc (AltheaDx) is a molecular diagnostics company that offers development of pharmacogenetics. The company provides tests such as cardiovascular tests, pain tests, thrombophilia tests and psychiatric tests. It provides diagnostic development, clinical trial and discovery services. A …
  • PharmAust Ltd (PAA):企業の財務・戦略的SWOT分析
    Summary PharmAust Ltd (PAA) is a clinical-stage company that focuses on the development of targeted cancer therapeutics for the treatment of human and veterinary cancers. The company’s lead product candidate Monepantel is a small molecule that has been developed to treat parasite infections in food …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆